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Cost savings of home nocturnal versus conventional in-center Hemodialysis patients traditionally receive three weekly
hemodialysis. treatments of four hours each, yet more frequent and
Background. Home nocturnal hemodialysis (HNHD) can lengthy sessions of dialysis are associated with improve-
improve clinical and biochemical factors in people with renal
ments in clinical parameters [1–3]. Home nocturnal he-failure, but its cost-effectiveness relative to conventional in-
modialysis (HNHD) is a technique developed in Torontocenter hemodialysis (IHD) is uncertain. We hypothesized that
in 1993, in which a patient performs treatments in theirHNHD would provide more dialysis treatments at a lower total
cost than IHD. home while asleep [4]. These individuals place themselves
Methods. A prospective one-year descriptive costing study on dialysis at night and disconnect themselves the follow-
was performed at two centers in Toronto, Canada, involving ing morning. On average, patients receive six treatmentspatients enrolled from a HNHD program (N  33), and a
per week, each lasting eight hours. In this group, im-matched cohort from an IHD program (N  23). All costs
provements have been seen in phosphate and potassiumare expressed as mean weekly amount in Canadian year 2000
dollars. A projected mean annual cost (PMA) was calculated levels, blood pressure, sleep patterns, ventricular hyper-
also. trophy and in quality of life (abstract; Brissenden et al,
Results. The mean number of treatments per week was much J Am Soc Nephrol 9:168A, 1999) [2, 5–10].
higher with HNHD (5.7 vs. 3.0, P  0.004). Cost categories Most research has concentrated on the clinical effectsfound to be less expensive for HNHD were staffing (weekly
of HNHD and few formal analyses of the costs of this$210 vs. $423, P  0.001, PMA $10,932 vs. $22,056) and over-
technique are available. Examinations of program budgetshead and support (weekly $80 vs. $238, P 0.001, PMA $4179
vs. $12,393). There was a trend toward lower costs for hospital are insufficient, as they fail to consider overall healthcare
admissions and procedures (weekly $23 vs. $134, P  0.355, expenditures. One study provided favorable analyses of
PMA $1173 vs. $6997) and for medications ($172 vs. $231, HNHD costs through examination of administrative data-
P  0.082, PMA $8989 vs. $12,029). Costs found to be more
bases, but these projections were performed without pro-expensive for HNHD were the cost of direct hemodialysis
spective patient-level data [11]. The general belief suggestsmaterials (weekly $318 vs. $126, P  0.001, PMA $16,587 vs.
that the cost of HNHD is less than conventional in-center$6575) and capital costs (weekly $118 vs. $17, P  0.001, PMA
$6139 vs. $871), with a trend toward higher cost for laboratory hemodialysis, which has been estimated to cost between
tests (weekly $33 vs. $26, P  0.094, PMA $1744 vs. $1364). CAN$80,000 to CAN$95,000 per patient-year [12–14].
Physician costs were the same at $128 per week (PMA $6650). A patient performing HNHD as practiced in Toronto
The weekly mean total cost for health care delivery was 20%
receives five to seven dialysis treatments per week, asless for HNHD ($1082 vs. $1322, P  0.006), with projected
compared to conventional in-center hemodialysis (IHD)mean annual costs more than $10,000 lower ($56,394 vs. $68,935).
where patients receive three treatments per week. WeConclusions. HNHD provides about three times as many
treatment hours at nearly a one-fifth lower cost, with savings conducted a one-year prospective descriptive costing
evident even when only program and funding-specific costs are study, to determine the costs of this newer method of
considered. dialysis, and to test the hypothesis that HNHD could
provide these additional dialysis treatments at a lower
total cost of health care delivery than IHD.
Key words: renal replacement therapy, cost analysis, dialysis, end-stage
renal disease, chronic renal disease, adequacy of dialysis, consumables
for dialysis.
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were eligible, except those on the modality for less than Number of treatments
three months during the study period. Selection criteria Methods were available to track the number of dialysis
for this program required that the patient show a capacity treatments provided to each patient during the study
for self-care training, functional literacy in English, and period. SMH tracks membrane usage at the patient level
a life expectancy of more than one year. In addition, the as part of a dialyzer reuse program. HRRH has contracts
patient was required to have sufficient manual, visual with private companies, which provide data for each treat-
and auditory abilities unless a spouse or other family ment on a patient-by-patient basis. A 5% random sample
member could assist during treatments. of treatment counts was audited against alternate sources
Selection criteria for the control hospital required that (run sheets, HNHD monitoring logs) to assess accuracy.
the hospital be university affiliated, located in the greater
Censoring of dataToronto area, have an in-center hemodialysis program
of sufficient size, and not have a home hemodialysis pro- As this was an on-treatment analysis, it was expected
that patients would have uneven durations of follow-upgram in operation. Based on these criteria, the control
due to either late entry (following modality training orgroup was formed from patients attending the hemodial-
program transfer) or early exit from their initial modalityysis clinic at St. Michael’s Hospital in Toronto (SMH).
(due to death, transplantation, or change of modalityControl patients were selected based on suitability for
type). To allow for variable follow-up, costs were ex-home dialysis. The SMH program medical director, who
pressed as the weekly cost of health care for each patient.was uninvolved with this study, was asked to screen all
Patient data were collected only while the patients wereSMH hemodialysis patients and identify those appro-
on their initial modality, and a mean weekly cost waspriate for home hemodialysis. Those selected were con-
calculated only for the time on-treatment.sidered eligible if they expressed an interest in home
hemodialysis after description of the modality, and might
Direct hemodialysis materials costs
consider switching from center-based hemodialysis. As
Direct hemodialysis materials expenses consisted ofnew patients entered both programs during the study
all consumables for hemodialysis, including the dialysisperiod, they were screened for eligibility and approached
membrane, medications delivered for dialysis (for exam-regarding enrollment.
ple, heparin), and additives to the dialysate (potassiumSigned consents approved by local and university eth-
chloride, calcium chloride, and fleet phosphasoda), asics review boards were obtained from all study subjects.
well as costs of monitoring treatments.
As SMH has a dialyzer reuse program, a programmaticCosting methods
analysis was performed to calculate the average cost of
Prospective costing data were collected from January 1,
reprocessing a membrane as well as the cost of purchasing
2000 to March 1, 2001. The primary analysis involved
a fresh membrane. For each patient, the number of fresh
calculation of a weekly total cost of health-care as viewed and reprocessed membranes used through the study pe-
from the perspective of the health-care provider. Costs riod was used to calculate their total membrane cost.
were expressed in year 2000 Canadian dollars. An on- Access-specific connectivity costs including cannulae
treatment analysis was used, and opportunity costs were for grafts and fistulae, and catheter caps for in-dwelling
excluded. We assumed that either dialysis modality was lines were calculated.
available to a patient, and so did not include an analysis A portion of the HNHD group was remotely moni-
of start-up costs or construction of new facilities. Capital tored during their treatments by either dedicated phone
costs were amortized over seven years, reflecting the line or the Internet. These costs were included for those
expected modality survival. patients who were monitored during the study period.
For cost items that were calculated on a per-treatments As not every item applied to each patient, an individu-
basis, the weekly cost was determined by multiplying alized per-treatment cost was determined accounting for
each patient’s per-treatment cost by their weekly average type of access, monitoring status, and hospital-specific
number of treatments. items. This calculation accounted for change of access
Because programs typically have annual rather than type and monitoring status through the study period.
weekly budgets, a projected annual cost was calculated
Staffingfor each patient by multiplying their weekly cost by 52.14.
Secondary analyses included a program-specific cost Salary and benefits for staff directly involved in the
including only the cost of direct hemodialysis materials, provision of dialysis care were determined through de-
staffing, overhead and support, and depreciation, and a tailed hospital records. This included nursing staff, assis-
unit-specific cost that examined only direct hemodialysis tants, technical personnel, and other professionals (such
as, pharmacists, social workers and dieticians). Manage-materials, staffing and overhead, and support costs.
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Table 1. Overhead and support costs was used. It was assumed that a generic form of each
medication was purchased unless specifically indicatedCategory Allocation unit
in the patient record. A 5% mark-up was added for medi-General hospital administration Paid hours
Medical records % Dictations cations acquired from pharmacies outside of the hospital.
Housekeeping Square metersa A dispensing fee of CAN$8.50 was added for all oral
Engineering Square metersa
medications for each 90 days of use.Laundry % Overall
Porters Paid hours In addition to overall medication usage, three catego-
Utilities Square metersa ries of medications were selected prospectively for sepa-
a Percentage of overall hospital floor space rate analysis: anemia therapy (including erythropoietin
and iron preparations), antibiotics, and cardiovascular
medications (including antihypertensives, anti-anginals
and therapies for ventricular dysfunction).
ment personnel were included to the level of the unit
manager, as were non-medical personnel such as secre- Admissions and procedures
taries and administrative assistants. Each in-patient admission was identified for all pa-
To further examine the differences in staffing costs, tients. Each hospital had existing methods for tracking
an analysis of staffing complements for the two programs in-patient direct and indirect costs at a patient level. Out-
was performed. The mean number of full-time equiva- patient interventional procedures were identified also
lents (FTE) for each staff category during the study pe- for each patient, with costs based on the government
riod was determined weekly on a per-patient basis. Schedule of Benefits, which included fees for physicians,
facilities, staffing and expendables.Overhead and support
Overhead and support consisted of costs for support Laboratory tests and medical imaging
services including housekeeping, dictation, laundry, en- The performance of laboratory and imaging studies
gineering, and porters. Also included were costs for ad- were tracked through a periodic review of the test results
ministrative personnel above the level of unit manager, section of the patient chart, as well as each hospital’s
the costs of consumables unrelated to the direct provision laboratory database. The cost of radiology tests was de-
of dialysis (for example, office supplies), and utilities. At termined from the government Schedule of Benefits,
SMH these costs are assigned through a single charge including both physician and technical fees. The cost of
as a percentage of the dialysis program annual budget. lab tests was based on charges by a private lab company
At HRRH, a series of calculations were performed to that provided the bulk of out-patient lab services. In-
allocate these costs to the HNHD program (Table 1). hospital test costs were based on fees charged at one
hospital (SMH).Medications
For each patient a drug profile was generated that Physician fees
tracked medication use on a daily basis. All oral, paren- The Ontario government Physician Schedule of Bene-
teral and over-the-counter medications were included fits was used to determine the cost of physician services
except those listed as a direct hemodialysis materials cost for the provision of dialysis care and for other services
or those delivered during an in-patient admission (which such as consultations and follow-up visits.
were captured as an Admission and Procedure cost). The
Depreciation/capital costsphysician order section, pharmacist notes, and computer-
based pharmacy records were reviewed periodically. By All forms of hemodialysis incur capital expenses for
determining the start and discontinuation dates of all equipment. The cost for acquisition of dialysis machines
medications, a daily drug profile was generated for each and water treatment equipment was determined. The
patient for every day of the study period. Drugs taken HNHD program required additional one-time items
only as needed were assigned an estimated number taken such as the initial setup of all equipment in the home
per day based on a patient interview. and enuresis sensors used to detect blood leaks.
A series of methods were used to assign a cost to As all patients performing HNHD must be trained
each medication. The Ontario Ministry of Health Drug to perform the modality, the cost of training also was
Benefit Formulary specifies the cost that the Ontario considered a depreciable expense. The average cost of
government has agreed to pay for most medications. training was determined by review of HRRH records,
For those not listed, hospital formularies and program and included staffing time as well as consumables used
purchase contracts were used to determine a drug’s cost. through the training period.
For medications not listed in these sources, the drug Capital items were categorized as either reusable (that
is, able to be used for a new patient if the current patientacquisition cost for a major international pharmacy chain
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Table 2. Demographics Intensity of treatment
IHD HNHD A total of 2609 patient-weeks of data were collected.
(N  23) (N  33) P value The mean number of weeks on modality during the study
Sex % male 69.6 75.8 0.84 period was 46  12 for HNHD and 48  9 for IHD
% with diabetes 6.1 13 0.67
(P  NS). The weekly average number of treatments% with CAD 8.7 15.2 0.76
% with CHF 4.3 21.2 0.12 for HNHD was almost two times greater for HNHD
% Post-secondary education 43.5 36.3 0.89 than IHD (5.7  0.9 vs. 3.0  0.4, P  0.001). Assuming
Age years 47.49.8 45.410.0 0.48
a four-hour average treatment time for IHD, and a mini-Duration ESRD years 5.85.6 7.76.5 0.26
mum treatment time of six hours for HNHD, the total
weekly dialysis time was at least 2.8 times greater with
HNHD (34.0 vs. 12.1 h/week, P  0.001).
dies or changes modality), or non-reusable. Examples of The measurement of dialysis adequacy in intensively
reusable items included dialysis machines, water purifi- dialyzed patients remains controversial. In the absence
cation equipment, and dialyzer reuse technology. Exam- of consensus, we calculated the single session and weekly
ples of non-reusable items included blood and other sen- single pool Kt/V during a representative period of the
sors, as well as the training costs for HNHD patients. study. The single session Kt/V for the HNHD group was
Reusable items were amortized over seven years, while 1.59  0.22, and was 1.36  0.17 for the IHD group.
non-reusable items were amortized over five years. A Weekly Kt/V was 9.1 for the HNHD group, and 4.1 for




Table 3 summarizes the weekly and projected annual
Demographic variables were analyzed as means (such costs for each modality. The overall cost of health care
as age) and proportion (such as sex) as appropriate. Cost delivery for HNHD was 20% lower than for IHD
variables were examined through comparison of weekly ($1,082  $155 vs. $1,322  $348, P  0.006). The pro-
mean values. Distribution shape and normality was jected annual cost for all categories was more than
checked for all variables using normal and detrended $10,000 less with HNHD than IHD ($56,394 vs. $68,935).
normal Q-Q plots and the Kolmogorov-Smirnov test When the scope was restricted to program- and funding-
with Lilliefor’s significance correction. Normally distrib- specific costs HNHD remained the less expensive option
uted means were compared using the Student t test, (Table 4). All but five of the IHD patients had mean
while variables failing normality testing were examined total annual costs higher than the mean total annual cost
using the Mann-Whitney U test. Chi-squared tests were of the HNHD group.
used for categorical variables. A significance level of 0.05 Home nocturnal hemodialysis achieved this cost sav-
was used for all tests. ing through reductions in several categories. Staffing
costs were half that of IHD, and overhead and support
RESULTS costs were reduced by two-thirds. There was a trend
toward fewer days admitted to hospital for the HNHDPatient population
group (1.8 vs. 6.8 admit-days/patient-year, P  0.13),A total of 38 patients participated in the HNHD pro-
resulting in a total cost for admissions and proceduresgram during the study period. Five were on the modality
that was 15% of the IHD cost (P  NS). There was alsofor less than three months during the study period. All
a trend suggesting 25% lower medication expenses inremaining 33 patients agreed to participate.
the HNHD group (P  0.08).One hundred and eighty-two patients from the IHD
These cost reductions made up for categories whereprogram were screened, and 29 were considered eligible
HNHD was more expensive. Costs for direct hemodialy-for home hemodialysis. Of these 29, three refused to
sis materials were more than two times higher than IHD.consider home dialysis and three declined to participate
Depreciable items were more than seven times morein the study, leaving 23 control patients. Over 2/3 of the
expensive for HNHD. The costs of outpatient labworkIHD patients were performing in-center self-care hemo-
trended toward being 25% higher for the HNHD groupdialysis. The HNHD and IHD groups had similar demo-
(P  0.094). The mean HNHD training cost in 2000 wasgraphic features (Table 2).
$10,201 per patient trained.By the end of the study period, 30 HNHD patients
were still on the modality, with three patients having
Direct hemodialysis materials costsreceived a transplant during the study period. Of the 23
The cost of 73 items required for the performance ofIHD patients, one died and two were transplanted by
the end of the study period. hemodialysis was tracked. These items ranged in price
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Table 3. Summary of costs
Measured weekly costs Projected annual costs
IHD HNHD P value IHD HNHD
Staff $423 $210 0.001 $22,056 $10,932
Direct hemodialysis materials $126 $318 0.001 $6,575 $16,587
Drug $231 $172 0.082 $12,029 $8,989
Overhead and support $238 $80 0.001 $12,393 $4,178
Physician fees $128 $128 N/A $6,650 $6,650
Admits/procedures $134 $23 0.355 $6,997 $1,173
Depreciation $17 $118 0.001 $871 $6,139
Lab tests/imaging $26 $33 0.004 $1,364 $1,744
Total $1,322 $1,082 0.006 $68,935 $56,394
All costs are expressed in year 2000 Canadian dollars.
Table 6. Selected staffing complementsTable 4. Cost comparison by costing perspective
IHD HNHD P value Staffing mean full-time
equivalents (FTE) per patient
All Costs
Per treatment $434$95 $194$37 0.001 IHD HNHD
Per week $1,322$348 $1,082$155 0.006
RN 0.22 0.06Projected annual $68,935 $56,394
Technical 0.04 0.06Program specific costsa
Clerical 0.02 0.03Per treatment $265$5 $129$5 0.001
Environmental 0.02 0.02Per week $804$97 $726$93 0.012
Social work 0.01 0.01Projected annual $41,895 $37,837
Dietician 0.01 0.01Funding specific costsb
Pharmacy 0.01 0.01Per treatment $260$5 $107$4 0.001
Per week $787$97 $608$93 0.001
Projected annual $41,024 $31,698
a Costs of direct hemodialysis materials, staffing, overhead and depreciation
Table 7. Medication costsb Costs of direct hemodialysis materials, staffing and overhead
IHD HNHD P value
EPO
Per week $182$124 $110$108 0.029Table 5. HNHD staffing composition
Projected annual $9,468 $5,712
IV ironStaffing mean full-time equivalents (FTE)
Per week $1.15$3.89 $27.79$30.02 0.001
RN 2.1 Projected annual $60 $1,449
Technical 2.0 Cardiovascular
Clerical 1.0 Per week $14.62$9.91 $3.66$5.32 0.001
Environmental 0.75 Projected annual $762 $191
Social worker 0.25 Antibiotics
Dietician 0.33 Per week $0.81$1.48 $3.41$4.40 0.003
Pharmacy 0.50 Projected annual $42 $178
(Table 6). The number of nursing staff per patient wasfrom $0.01 to $11.00. The average cost per treatment for
these items was about a quarter higher with HNHD than about 3/4 less for HNHD.
The staff for both hospitals shared the same unionsIHD ($56.16  $3.55 vs. $41.64  $5.08, P 0.001). The
cost to remotely monitor a patient via Internet for all for nursing, technical and support staff, leading to a
shared pay scale for the majority of the employees.treatments over a one-year period was $3,096.
Staffing Medications
Table 7 outlines the differences seen in the pre-speci-The number of patients and staffing levels changed
across the study period for both programs. Table 5 out- fied medication categories. Erythropoietin (EPO) use
and cardiovascular medications were significantly lesslines the typical staffing level for the HNHD program,
serving approximately 35 patients. The specific compara- in the HNHD group, while IV iron preparations and
antibiotics were significantly more. Significantly lesstive staffing analysis demonstrated that the mean number
of full-time-equivalent staff for each staffing category EPO was used by the HNHD group (mean weekly dose
7,301  7,282 units vs. 11,869  8575 units, P  0.036).was similar for both groups with the exception of nursing
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Table 8. Capital amortization period sensitivity analysis hemodialysis program. While this yielded an assessment
of an established and mature program, the number ofReusable Non-reusable
Projected annualitema itemb
Weekly total cost total cost
patients enrolled remained small relative to most in-
HNHD IHD P value HNHD IHD
Amortization period center hemodialysis programs, affecting the variability
years of our results. Additionally, our results describe the find-
7 ings in a single center. New and smaller programs may
5 $1,082 $1,322 0.01 $56,394 $68,935 not realize some of the economies of scale seen here,
4 $1,091 $1,322 0.01 $56,870 $68,935
while established programs may exceed these results3 $1,106 $1,322 0.02 $57,665 $68,935
2 $1,136 $1,322 0.08 $59,255 $68,935 through additional efficiencies. Furthermore, this mature
5 nocturnal hemodialysis program includes a broad mix of
5 $1,114 $1,329 0.02 $58,085 $69,283
patients, with varying levels of medical complexity. It is4 $1,123 $1,329 0.04 $58,562 $69,284
3 $1,138 $1,329 0.07 $59,357 $69,284 likely that new programs will select healthier patients
2 $1,169 $1,329 0.25 $60,947 $69,284 initially. This is not likely to significantly affect the costs
a Reusable items include dialysis machines, centrifuges, water treatment and of performing HNHD, but may change the savings seen
reuse equipment
in other areas such as hospital admissions. As programsb Non-reusable items include patient training, sensors, tourniquets, and home
specific equipment mature, and the penetration of HNHD increases, it is
likely that the reductions in non-modality expenses will
improve.
Although we calculated the cost of depreciable equip-Physician fees
ment and training, we did not calculate the cost of new
In Ontario, physicians providing dialysis care receive facilities or start-up costs, which could be substantial in
a weekly modality-independent fee for all medical ser- a new program. For these reasons, new HNHD programs
vices, leading to an identical weekly cost of $127.55 per may not fully realize the overall cost savings described
patient (projected mean annual cost of $6650). Outside here in the initial phases. Potential savings will also
of nephrologic care, there were few physician encounters change as the patient mix shifts away from the healthiest
in both groups that did not lead either to an admission individuals. Additional research will be needed as the
or an intervention. Although attempts were made to use of HNHD spreads, and as existing programs grow.
track these remaining physician encounters, charting and In addition to studying the cost of HNHD, we at-
patient recall of these events was found to be unreliable. tempted to compare the costs to those seen in a similar
The mean number of identified encounters was small group of individuals who were performing in-center he-
and similarly judged too unreliable for analysis. modialysis. To minimize the selection bias inherent in a
non-randomized design, we selected a hospital where
Sensitivity analysis there were patients eligible for home hemodialysis, but
As depreciable expenses were significantly different where a home hemodialysis program did not exist. Our
between the groups, and a long amortization period was selection process produced groups that were demograph-
chosen for the primary analysis, a sensitivity analysis was ically similar, with a trend toward more congestive heart
undertaken to determine the impact of shorter amortiza- failure at baseline in the HNHD group (HNHD was used
tion periods on the total weekly and projected annual as “rescue” therapy for some individuals with frequent
costs. HNHD remained the less costly option in all sce- exacerbations of heart failure). While the two groups
narios. When a seven-year period is selected for reusable were similar, neither group is similar to the “average”
items, the cost difference is statistically significant only hemodialysis patient. The individuals in this study tended
if the patient remains on the modality for more than two to be younger, were unlikely to have diabetes, and had
been on dialysis for a prolonged period. Our conclusions,years. If the reusable amortization period is reduced to
therefore, should not be generalized to the broader dial-five years, a patient must stay on HNHD for more than
ysis population. Although this study did not address thethree years before statistical significance is reached (Ta-
question of who is capable of performing home nocturnalble 8).
hemodialysis, our selection process identified less than
16% of the patients from the SMH dialysis unit as being
DISCUSSION potentially eligible.
While there are many estimates of the cost of conven- While selection bias was minimized by the selection
tional hemodialysis, there exists no prospective patient- of our control hospital and patients, this bias can only
level estimate of the cost of home nocturnal hemodialy- be fully avoided through the performance of a large-
sis. Our first goal was to produce an estimate of the scale prospective trial, with randomization of patients to
cost of this new modality. To our knowledge, this study their form of dialysis.
While methodological requirements led to the selec-examined the world’s first and largest home nocturnal
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